ABT-925 HCl
ABT-925, also known as A-37203, BSF-201640; DAT-201; Lu-201640; and A-437203, is a selective dopamine D3 receptor (DRD3) antagonist with an approximately 100-fold higher in vitro affinity for dopamine D₃ versus D₂ receptors. ABT-925 was tested in schizophrenia. ABT-925 is a selective dopamine D₃ receptor antagonist with an approximately 100-fold higher in vitro affinity for dopamine D₃ versus D₂ receptors.
Supplier | Ace Therapeutics |
---|---|
Product # | SMD1358 |
CAS # | ABT-925 HCl |
Pricing | Customizable size, Inquiry |
Synonym | A 37203; A-37203; A37203; A 437203; A437203; A-437203; ABT 925; ABT925; ABT-925; BSF 201640; BSF201640; BSF-201640; DAT 201; DAT201; DAT-201; Lu 201640; Lu201640; Lu-201640; |
Product Category | Lab-use Small Molecule Drugs |
Chemical Formula | C20H29Cl2F3N6OS |
Molecular Weight | 529.45 |
Elemental Analysis | C, 45.37; H, 5.52; Cl, 13.39; F, 10.77; N, 15.87; O, 3.02; S, 6.06 |
IUPAC/Chemical Name | 2-[[3-[4-[2-(1,1-Dimethylethyl)-6-(trifluoromethyl)-4-pyrimidinyl]-1-piperazinyl]propyl]thio]-4(3H)-pyrimidinone dihydrochloride |
InChi Key | YSJHYIFQGZFVIP-UHFFFAOYSA-N |
InChi Code | InChI=1S/C20H27F3N6OS.2ClH/c1-19(2,3)17-25-14(20(21,22)23)13-15(26-17)29-10-8-28(9-11-29)7-4-12-31-18-24-6-5-16(30)27-18;;/h5-6,13H,4,7-12H2,1-3H3,(H,24,27,30);2*1H |
SMILES Code | O=C1NC(SCCCN2CCN(C3=NC(C(C)(C)C)=NC(C(F)(F)F)=C3)CC2)=NC=C1.[H]Cl.[H]Cl |
Appearance | Solid powder |
Purity | >98% (or refer to the Certificate of Analysis) |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Shelf Life | >3 years if stored properly |
Drug Formulation | This drug may be formulated in DMSO |
Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
HS Tariff Code | 2934.99.9001 |